Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Oksana Veselova"'
Autor:
Marina Palkeeva, Irina Studneva, Alexander Molokoedov, Larisa Serebryakova, Oksana Veselova, Michael Ovchinnikov, Maria Sidorova, Oleg Pisarenko
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss , Pp 1556-1562 (2019)
N-terminal fragments of galanin (2–11) and (2–15) are critical for binding to GalR1-3 receptors, members of the G-protein-coupled receptor superfamily, and are involved in myocardial protection against ischemia/reperfusion (I/R) injury. This stud
Externí odkaz:
https://doaj.org/article/8c7de67e93af4efc868e2271aa231ebf
Autor:
Maria Sidorova, Alexander A. Timoshin, Irina Studneva, M. V. Ovchinnikov, L. I. Serebryakova, A. S. Molokoedov, A. A. Az’muko, Oksana Veselova, Oleg I. Pisarenko, Pal'keeva Me
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2039-2048
Natural and chemically modified N-terminal galanin fragments (WTLNSAGYLLGPHA-OH (G1) and WTLNSAGYLLGPβAH-OH (G2), respectively) reduce functional and metabolic disturbances in the heart during experimental ischemia and reperfusion. The aim of this w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54baa3a53f72d40e2957f44278c1f1fb
https://doi.org/10.1007/s10989-021-10231-x
https://doi.org/10.1007/s10989-021-10231-x
Autor:
Oksana Veselova, Irina Studneva, Igor Dobrokhotov, Marina Pal’keeva, Alexander Molokoedov, Maria Sidorova, Oleg Pisarenko
Publikováno v:
International Journal of Peptide Research and Therapeutics. 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a41398076374cec33d2d0c342f3e8aa
https://doi.org/10.1007/s10989-022-10412-2
https://doi.org/10.1007/s10989-022-10412-2
Autor:
Arthur A. Bahtin, Irina Studneva, Galina G. Konovalova, Vadim Z. Lankin, Oksana Veselova, Oleg I. Pisarenko
Publikováno v:
Acta Naturae
The use of the anticancer drug doxorubicin (Dox) is limited by its cardiotoxic effect. The aim of this work was to study the effect of a new synthetic agonist of the galanin receptor GalR1-3 [Ala14, His15]-galanine (215) (G) on the metabolism, antiox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1707350dafb0fd84e47f992128cb4090
http://europepmc.org/articles/PMC7245963
http://europepmc.org/articles/PMC7245963
Publikováno v:
Pflügers Archiv - European Journal of Physiology. 471:583-593
Disturbed homeostasis of nitric oxide (NO) is one of the causes of myocardial ischemia/reperfusion (I/R) injury during open-heart surgery. This study was designed to explore mechanisms of action of dinitrosyl iron complexes with reduced glutathione (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edc44b0d3e8d033b9e57a18031b91a4f
https://doi.org/10.1007/s00424-018-02251-2
https://doi.org/10.1007/s00424-018-02251-2
Autor:
Oleg I. Pisarenko, Maria Sidorova, Oksana Veselova, Irina Studneva, A. S. Molokoedov, Pal'keeva Me, L. I. Serebryakova, M. V. Ovchinnikov, Radik Gataulin
Publikováno v:
Peptides. 111:127-131
Agonists and antagonists for galanin receptor subtypes GalR1-3 can be used as putative therapeutics targets for the treatment of various human diseases. However, effects of galanin and its N-terminal fragments on myocardial ischemia/reperfusion injur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e2f581860c81b32645b3754c018b00
https://doi.org/10.1016/j.peptides.2018.05.001
https://doi.org/10.1016/j.peptides.2018.05.001
Autor:
M. V. Ovchinnikov, L. I. Serebryakova, A. S. Molokoedov, Pal'keeva Me, Oleg I. Pisarenko, Irina Studneva, Oksana Veselova, Maria Sidorova
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss, Pp 1556-1562 (2019)
N-terminal fragments of galanin (2–11) and (2–15) are critical for binding to GalR1-3 receptors, members of the G-protein-coupled receptor superfamily, and are involved in myocardial protection against ischemia/reperfusion (I/R) injury. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c099d8abec6e33759a0adafea5a62d
https://doi.org/10.1016/j.biopha.2018.09.182
https://doi.org/10.1016/j.biopha.2018.09.182
Autor:
Maria Sidorova, Pal'keeva Me, Frederic Boal, Oleg I. Pisarenko, Oksana Kunduzova, Hélène Tronchère, Andrei Timotin, Irina Studneva, Oksana Veselova, Mathieu Cinato, Aleksander Molokoedov, Shul'zhenko Vs, L. I. Serebryakova
Publikováno v:
Oncotarget
// Oleg Pisarenko 1, * , Andrei Timotin 2, 3, * , Maria Sidorova 1 , Irina Studneva 1 , Valentin Shulzhenko 1 , Marina Palkeeva 1 , Larisa Serebryakova 1 , Aleksander Molokoedov 1 , Oksana Veselova 1 , Mathieu Cinato 2, 3 , Frederic Boal 2, 3 , Helen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942e0c01f2a95c72d6f6c7a6b5c24a0a
https://doi.org/10.18632/oncotarget.21503
https://doi.org/10.18632/oncotarget.21503
Publikováno v:
Journal of Physiology and Biochemistry. 74:283-290
The maintenance of nitric oxide (NO) bioavailability has been recognized as an important component of myocardial protection during cardiac surgery. This study was designed to evaluate the efficacy of using two NO-donating compounds in cardioplegia an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997e06b2d74605acb0f1dcc6d932cf3c
https://doi.org/10.1007/s13105-018-0614-4
https://doi.org/10.1007/s13105-018-0614-4
Autor:
Alexander A. Timoshin, Pal'keeva Me, Maria Sidorova, A. A. Az’muko, A. S. Molokoedov, Oleg I. Pisarenko, Oksana Veselova, Irina Studneva, M. V. Ovchinnikov, L. I. Serebryakova
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2049-2049
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6565bdf75ca5ad8f21aa03eff99c5eff
https://doi.org/10.1007/s10989-021-10233-9
https://doi.org/10.1007/s10989-021-10233-9